Odylia CEO speaks at NIH/NCATS conference (video)

Odylia CEO Scott Dorfman presented the Odylia concept to the National Institutes of Health and National Center for Advancing Translational Sciences (NCATS) at a conference on The Growing Promise of Gene Therapy Approaches. Please skip to 4:18:00 to see the Odylia talk and followup panel discussion.


Please click HERE to view the video